Clofarabine With Cytarabine for MRD Positive Leukemia.

Trial Profile

Clofarabine With Cytarabine for MRD Positive Leukemia.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2013

At a glance

  • Drugs Clofarabine (Primary) ; Cytarabine (Primary) ; Cytarabine (Primary) ; Methotrexate
  • Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Oct 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 19 Aug 2010 Actual initiation date (Aug 2010) added as reported by ClinicalTrials.gov.
    • 19 Aug 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top